Vaccine Strategies Against CDI

[Virtual Post Bioclues]

 

Transforming knowledge into impact   Join us! Clostridioides difficile infection (CDI) remains a leading cause of healthcare- and antibiotic-associated infections, with a 30% recurrence rate. Join our upcoming webinar to find out why the route of delivery determines whether a vaccine clears CDI or simply masks its damage. Topics discussed in this webinar will include: • Immunological comparisons between mucosal and parenteral vaccine administration routes • How distinct mechanisms drive C. difficile clearance and lasting protection • Insights into how targeting mucosal immunity can redefine vaccine strategies for enteric pathogens REGISTER NOW   Our Speaker   Dr. Audrey K. Thomas, Vanderbilt University Medical Center Dr. Audrey K. Thomas earned her Ph.D. in Microbiology and Immunology and is currently a postdoctoral fellow in Dr. D. Borden Lacy's laboratory at Vanderbilt University Medical Center. Her research focuses on leveraging structural biology to design vaccines that elicit targeted, localized immune responses. This activity is supported by sponsorship from Cytek Biosciences and partnership with Current Protocols.